Invited review
Tachykinin receptor types: Classification and membrane signalling mechanisms

https://doi.org/10.1016/0197-0186(91)90180-LGet rights and content

Abstract

The use of selective agonists in both functional and binding studies has provided unequivocal evidence for the existence of three types of tachykinin receptor (NK1, NK2 and NK3); there is also preliminary evidence for the existence of further subtypes. These results have been confirmed by the development of selective antagonists and by the identification and cloning of three distinct cDNA sequences. All three receptors belong to the superfamily of G protein coupled receptors and are linked to the phosphoinositide transmembrane-signalling pathway. The purpose of this article is to review recent developments in the pharmacology of each receptor with emphasis on the NK3 type. In particular, the need to use selective agonists and antagonists to identify each receptor type is stressed.

References (139)

  • M.A. Cascieri et al.

    Characterization of the substance P receptor in rat brain cortex membranes and the inhibition of radioligand binding by guanine nucleotides

    J. biol. Chem.

    (1983)
  • M.A. Cascieri et al.

    Binding of [125I]-Bolton Hunter conjugated eledoisin to rat brain cortex membranes—evidence for two classes of tachykinin receptors in the mammalian central nervous system

    Life Sci.

    (1984)
  • M.A. Cascieri et al.

    Demonstration of two distinct tachykinin receptors in rat brain

    J. biol. Chem.

    (1985)
  • J.M. Conlon et al.

    Scyliorhinin I and II: two novel tachykinins from dogfish gut

    FEBS Lett.

    (1986)
  • J.M. Conlon et al.

    [Arg3]substance P and neurokinin A from chicken small intestine

    Regul. Pept.

    (1988)
  • A.C. Cuello

    Peptides as neuromodulators in primary sensory neurons

    Neuropharmacology

    (1987)
  • T.-V. Dam et al.

    Apparent molecular weight of substance P/neurokinin-1 receptors determined using a photoaffinity labelled probe, [(3′-125I)DTyr0,(4′-N3)Phe8,Nle11]-substance P

    Biochem. biophys. Res. Commun.

    (1987)
  • T.-V. Dam et al.

    Visualisation of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]-senktide

    Brain Res.

    (1990)
  • J.A. Danks et al.

    A comparative autoradiographic study of the distributions of substance P and eledoisin binding sites in the rat brain

    Brain Res.

    (1986)
  • A.Y. Deutch et al.

    Substance K and substance P differentially modulate mesolimbic and mesocortical systems

    Peptides

    (1985)
  • C.P. Downes

    Agonist-stimulated phosphatiylinositol 4,5-bisphosphate metabolism in the nervous system

    Neurochem. Int.

    (1986)
  • G. Drapeau et al.

    Selective agonists for substance P and neurokinin receptors

    Neuropeptides

    (1987)
  • D. Eardley et al.

    Both substance P agonists and antagonists inhibit ion conductance through nicotinic acetylcholine receptors on PC12 cells

    Eur. J. Pharmac.

    (1985)
  • V. Erspamer

    The tachykinin peptide family

    Trends Neurosci.

    (1981)
  • A. Franco-Cereceda et al.

    Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man, distribution and release by capsaicin

    Peptides

    (1987)
  • A.B. Hawcock et al.

    Agonist effects of [dPro2,dPhe7,dTrp9]substance P—evidence for different receptors

    Eur. J. Pharmac.

    (1982)
  • J.C. Hunter et al.

    Mammalian tachykinin-induced hydrolysis of inositol phospholipids in rat brain slices

    Biochem. biophys. Res. Commun.

    (1985)
  • J.C. Hunter et al.

    Pharmacological analysis of 125I-Bolton and Hunter labelled eledoisin binding sites in rat spinal cord by quantitative autoradiography

    Neurosci. Lett.

    (1987)
  • S.J. Ireland et al.

    Receptors mediating the contractile response to neurokinin agonists in the guinea-pig trachea

    Regul. Pept.

    (1988)
  • L.K. Kaczmarek

    The role of protein kinase C in the regulation of ion channels and neurotransmitter release

    Trends Neurosci.

    (1987)
  • K. Kangawa et al.

    Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord

    Biochem. biophys. Res. Commun.

    (1983)
  • A. Laniyonu et al.

    Different tachykinin receptor subtypes are coupled to the phosphoinositide or cyclic AMP signal transduction pathways in rat submandibular cells

    FEBS Lett.

    (1988)
  • R. Laufer et al.

    Characterization of a neurokinin B receptor site in rat brain using a highly selective radioligand

    J. biol. Chem.

    (1986)
  • S. Lavielle et al.

    A cyclic analogue selective for the NKB specific binding site on rat brain synaptosomes

    Eur. J. Pharmac.

    (1986)
  • Y. Lee et al.

    Distribution of calcitonin gene-related peptide in the rat peripheral nervous system with reference to its co-existence with substance P

    Neuroscience

    (1985)
  • C.-M. Lee et al.

    Multiple tachykinin binding sites in peripheral tissues and brain

    Eur. J. Pharmac.

    (1986)
  • R.J. Lefkowitz et al.

    Adrenergic receptors: models for the study of receptors coupled to guanine nucleotide regulatory proteins

    J. biol. Chem.

    (1988)
  • R.J. Lefkowitz et al.

    The new biology of drug receptors

    Biochem. Pharmac.

    (1989)
  • A.T. McKnight et al.

    Pharmacological specificity of synthetic peptides as antagonists at tachykinin receptors

    Regul. Pept.

    (1988)
  • A. Anastasi et al.

    Amino acid composition and sequence of kassinin, a tachykinin dodecapeptide from the skin of the African frog Kassina senegalensis

    Experentia

    (1977)
  • J.C. Beaujouan et al.

    Specific binding of an immunoreactive and biologically active 125I-labelled substance P derivative to mouse mesencephalic cells in primary culture

    Molec. Pharmac.

    (1982)
  • J.C. Beaujouan et al.

    A new type of tachykinin binding site in the rat brain characterized by the specific binding of a labelled eledoisin derivative

    Molec. Pharmac.

    (1984)
  • J.C. Beaujouan et al.

    Quantitative autoradiographic analysis of the distribution of binding sites for [125I]-Bolton Hunter derivatives of eledoisin and substance P in the rat brain

    Neuroscience

    (1986)
  • L. Bergström et al.

    3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle

    Molec. Pharmac.

    (1987)
  • L. Bergström et al.

    3H-neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain

    J. Neurochem.

    (1987)
  • M.J. Berridge et al.

    Inositol phosphates and cell signalling

    Nature

    (1989)
  • M.J. Berridge et al.

    Lithium amplifies agonist-dependent phosphatidlyinositol responses in brain and salivary glands

    Biochem. J.

    (1982)
  • D.R. Bristow et al.

    Effects of tachykinins on inositolphospholipid hydrolysis in slices of hamster urinary bladder

    Br. J. Pharmac.

    (1987)
  • J.R. Brown et al.

    Studies with tachykinin antagonists on neuronal preparations in vitro

  • S.H. Buck et al.

    Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor

    Science

    (1984)
  • Cited by (359)

    • Substance P and neurotensin in the limbic system: Their roles in reinforcement and memory consolidation

      2018, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      In the BLA, mainly GABAergic interneurons and in a lesser extent glutamatergic projection neurons (Maubach et al., 2001), while in the CeA, GABAergic projection neurons express NK1 receptors (Sosulina et al., 2015). Affinity of SP to NK1 receptors is about hundred-fold than to the NK2 or NK3 receptors (Guard and Watson, 1991), however, actions of SP on these two latter receptors have to be taken into consideration as well. NK2 receptors are located mainly in the thalamus, hippocampus, infralimbic and prelimbic cortex (Saffroy et al., 2003).

    • Substance P and the neurokinin-1 receptor expression in dog ileum with and without inflammation

      2017, Research in Veterinary Science
      Citation Excerpt :

      The effects of SP are mediated by three neurokinin (NK) receptors, belonging to the G-protein receptor superfamily: NK1R, NK2R, and NK3R. The NK1R is the high-affinity receptor for SP, while NK2R and NK3R bind with lower affinity to this peptide (Guard and Watson, 1991; Lomax et al., 1998; Shimizu et al., 2008). Nevertheless, SP can interact with all tachykinin receptor types with the ability to stimulate and/or inhibit propulsive motility (Holzer, 1997; Shimizu et al., 2008).

    • Role of substance P in the cardiovascular system

      2016, Neuropeptides
      Citation Excerpt :

      SP binds preferentially to NK1 receptors (Mantyh, 2002), whereas NKA and NKB display highest affinity for the NK2 and NK3 receptors, respectively (Kerdelhue et al., 1997, Stahl, 1999). The rank order potency of tachykinins is SP > NKA > NKB for the NK1 receptor, NKA > NKB > SP for the NK2 receptor and NKB > NKA > SP for the NK3 receptor (Guard and Watson, 1991, Maggi, 1995). The structural unit of NK1 receptor is formed by seven hydrophobic transmembrane domains, extracellular and intracellular loops.

    • Tachykinins

      2013, Handbook of Biologically Active Peptides
    • Roles of substance P and ATP in the subepithelial fibroblasts of rat intestinal villi

      2013, International Review of Cell and Molecular Biology
      Citation Excerpt :

      The tachykinins released act on tachykinin receptors (NK1, NK2, NK3) on the various cells (Nakanishi, 1991; Pennefather et al., 2004; Quartara and Maggi, 1997, 1998). They can interact with multiple G proteins, which couple to phospholipase C via Gq and to adenyl cyclase via Gs, and thus stimulate phosphatidylinositol hydrolysis and cyclic AMP formation, respectively (Guard and Watson, 1991; Nakajima et al., 1992; Nakanishi et al., 1993). In NK1R transfected Chinese hamster ovary (CHO) cells, SP-stimulated cAMP accumulation was high as compared with NK3R–CHO cells (Nakajima et al., 1992).

    View all citing articles on Scopus

    Present address: Parke-Davis Research Unit, Addenbrookes Hospital Site, Hills Road, Cambridge CB2 2QB, U.K.

    View full text